This inventor holds 3 USPTO granted patents. Top assignees: The Procter Gamble Company, Genetech, Inc., Gilead Connecticut, Inc.. Active years: 2003-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2003-2013
Title: The Innovations of William Martin Rennells
Introduction
William Martin Rennells is a notable inventor based in Schenectady, NY (US). He holds a total of 3 patents that reflect his contributions to the field of pharmaceuticals and chemical synthesis. His work has significantly impacted methods of treating diseases and developing new compounds.
Latest Patents
Rennells' latest patents include innovative methods and compounds. One of his patents focuses on Pyridazinones, which describes compounds of Formula I that inhibit Btk. This patent outlines pharmaceutical compositions that comprise at least one compound of Formula I, along with pharmaceutically acceptable vehicles. It also details methods for treating patients suffering from diseases responsive to Btk activity inhibition and methods for determining the presence of Btk in a sample. Another significant patent involves methods for synthesizing amino-tetrahydroisoquinoline ring compounds. This patent describes the preparation of amino-substituted-tetrahydroisoquinoline compounds through a series of chemical reactions.
Career Highlights
Throughout his career, Rennells has worked with prominent companies such as Procter & Gamble and Genentech, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.
Collaborations
Rennells has collaborated with notable coworkers, including Song Liu and Antonio J M Barbosa. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
William Martin Rennells is a distinguished inventor whose work in pharmaceuticals and chemical synthesis has led to significant advancements in the field. His patents demonstrate his commitment to innovation and improving patient care through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile